Sodium Monofluoroacetate (1080)

Chapter 77 Sodium Monofluoroacetate (1080)





Sodium monofluoroacetate (fluoroacetate, SMFA, and compound 1080) is a pesticide used to control rodents and other pests in the United States and worldwide. Commonly termed 1080, this compound was identified as an effective rodenticide in the 1940s. Fluoroacetamide (compound 1081) was developed soon afterward as a less toxic alternative to 1080.1 Both compounds are white, odorless, tasteless, water soluble, and highly toxic poisons.2 Fluoroacetate also occurs naturally in a variety of plants in Africa (Dichapetalum cymosum and Dichapetalum toxicarium), Australia (Acacia georginae, Gastrolobium spp and Oxylobium spp), and South America (Palicourea marcgravii).1 These and other plants containing fluoroacetate are known to poison livestock. Because these compounds are toxic to carnivores, they have been manufactured for the control of predators, such as the coyote (Canis latrans). At the present time, the use of 1080 is restricted to trained, licensed applicators. Although this restriction is intended to control its release in the environment and to target specific predators, unintentional poisoning of nontargeted animals occurs. In the United States the only currently registered use of 1080 is in a livestock protection collar for sheep and goats. There is no currently registered use of 1081 in the United States.3


Compound 1080 is also an important toxic metabolite associated with the chemotherapeutic anticancer agent 5-fluorouracil and some fluorinated ethanes that may be toxic when inhaled.46 Clinical signs associated with the adverse effects of 5-fluorouracil and fluorinated ethanes resemble those seen with 1080 toxicity.5,6





MECHANISM OF TOXICITY


Compounds 1080 and 1081 are readily absorbed from the gastrointestinal and respiratory tracts, abraded skin, and mucous membranes, but not through intact skin. They are not known to accumulate in any one tissue.1


The classic theory of 1080 poisoning is the so-called lethal synthesis effect on the Krebs or tricarboxylic acid (TCA) cycle (Figure 77-1). Fluoroacetate and fluoroacetamide combine with acetyl coenzyme A (CoA) to form fluoroacetyl CoA, which then combines with oxaloacetate to produce fluorocitrate. Fluorocitrate inhibits aconitase and the oxidation of citric acid, resulting in blockage of the TCA cycle, energy depletion, citric and lactic acid accumulation, and a decrease in blood pH.2 The inhibition of aconitase interferes with cellular respiration and the metabolism of carbohydrates, fats, and proteins.1,2 Recent work presents evidence that fluorocitrate is converted to 4-hydroxy-trans-aconitate, which binds very tightly to aconitase, thereby inactivating it.8 The end result is an accumulation of citrate, which binds with serum calcium. The decrease in available ionized calcium has been shown to prolong the QT interval in electrocardiograms in cats.9


Stay updated, free articles. Join our Telegram channel

Sep 11, 2016 | Posted by in SMALL ANIMAL | Comments Off on Sodium Monofluoroacetate (1080)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access